Infacalm

Simeticone, the active ingredient in Infacalm, is an antiflatulent presented as an oral formulation for oral use. It helps relieve excess gas, bloating and flatulence in adults and children by facilitating the elimination of gas from the gastrointestinal tract.

GNH USA supplies Infacalm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions. Products are shipped with full documentation to meet regulatory requirements.

Infacalm, containing simeticone, is used to manage gastrointestinal conditions characterized by excess gas.

- Gas: Reduces the volume of intestinal gas, providing symptomatic relief. - Bloating: Decreases abdominal distension by promoting gas coalescence and elimination. - Flatulence: Facilitates the passage of gas, reducing the frequency of passing wind.

Simeticone is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Mild abdominal discomfort: transient stomach uneasiness. - Nausea: occasional feeling of queasiness. - Diarrhea: loose stools in a small number of patients. - Taste alteration: slight metallic or bitter taste.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or hives requiring medical attention. - Anaphylaxis: rare severe hypersensitivity with difficulty breathing or shock.

When using Infacalm, consider the following precautions to ensure safe and effective use.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Children: dosage and suitability should be determined by a prescriber. - Hypersensitivity: avoid if known allergy to simeticone or formulation excipients. - Drug interactions: review concomitant medications with a pharmacist. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Simeticone has minimal systemic absorption, yet certain drug combinations may require attention.

Major Interactions (Avoid): - None identified: no major drug interactions reported.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may reduce simeticone efficacy; monitor symptom control. - Antibiotics (e.g., amoxicillin): can increase gas production; observe for worsening symptoms. - Proton pump inhibitors: may alter gastrointestinal environment; assess need for dose adjustment. - Laxatives: combined effect on bowel motility; watch for abdominal discomfort.